This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_TRACHEA_EXALLC for full statistics.
Carcinoma in situ of trachea
CD2_INSITU_TRACHEA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
520195 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5 |
4. Check minimum number of eventsNone |
5 |
5. Include endpointsNone |
5 |
6. Filter based on genotype QC (FinnGen only) |
5 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
- Parent code in ICD-10
- D02
- Name in latin
- Carcinoma in situ cutis
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of trachea
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of trachea
- Carcinoma in situ of middle ear and respiratory system
- Carcinoma in situ of middle ear and respiratory system
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
Not enough data for upset plot.
Not enough data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5 | - | - |
| Unadjusted period prevalence (%) | 0.00 | - | - |
| Median age at first event (years) | 59.41 | - | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(36304419) Bacteria [Presence] in Urine
5
16
+∞
2.23
1.0
2.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
5
20
+∞
1.82
1.0
3.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
0
16
0.00
0.51
0.0
3.2
—
50.6
—
0
16
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
0
17
0.00
0.51
0.0
1.8
—
185.4
—
0
17
(3003694) ABO and Rh group [Type] in Blood
0
11
0.00
0.24
0.0
1.2
—
—
—
0
0
(3013512) EKG study
0
11
0.00
0.24
0.0
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5
39
+∞
0.24
16.2
17.8
ml/min/173m2
71.2
78.1
—
5
29
(1761868) Lipid panel - Serum or Plasma
0
11
0.00
0.24
0.0
4.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5
40
+∞
0.24
25.4
18.6
%
14.8
13.7
—
5
40
(3044889) 12 lead EKG panel
5
40
+∞
0.24
3.2
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
0
10
0.00
0.24
0.0
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
0
10
0.00
0.24
0.0
1.2
—
12.6
—
0
5
(3021447) Carbon dioxide [Partial pressure] in Venous blood
0
5
0.00
0.00
0.0
1.2
—
6.1
—
0
5
(3003458) Phosphate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
1.0
—
0
7
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
5
0.00
0.00
0.0
4.2
—
0.2
—
0
5
(36660697) Celiac disease serology panel - Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
2.5
—
0
5
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3012544) pH of Venous blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
6.0
—
101.2
—
0
6
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
5
45
+∞
-0.00
15.6
16.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_TRACHEA – Carcinoma in situ of trachea
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).